These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
728 related articles for article (PubMed ID: 19744959)
1. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice. Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959 [TBL] [Abstract][Full Text] [Related]
2. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice. Chakkalakal JV; Harrison MA; Carbonetto S; Chin E; Michel RN; Jasmin BJ Hum Mol Genet; 2004 Feb; 13(4):379-88. PubMed ID: 14681302 [TBL] [Abstract][Full Text] [Related]
3. Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle. Ljubicic V; Miura P; Burt M; Boudreault L; Khogali S; Lunde JA; Renaud JM; Jasmin BJ Hum Mol Genet; 2011 Sep; 20(17):3478-93. PubMed ID: 21659335 [TBL] [Abstract][Full Text] [Related]
4. Targeted inhibition of Ca2+ /calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle. Chakkalakal JV; Michel SA; Chin ER; Michel RN; Jasmin BJ Hum Mol Genet; 2006 May; 15(9):1423-35. PubMed ID: 16551657 [TBL] [Abstract][Full Text] [Related]
5. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Tidball JG; Wehling-Henricks M Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129 [TBL] [Abstract][Full Text] [Related]
6. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy. D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791 [TBL] [Abstract][Full Text] [Related]
8. Evolution of pathological changes in the gastrocnemius of the mdx mice correlate with utrophin and beta-dystroglycan expression. Roma J; Munell F; Fargas A; Roig M Acta Neuropathol; 2004 Nov; 108(5):443-52. PubMed ID: 15365724 [TBL] [Abstract][Full Text] [Related]
10. Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle. Tanihata J; Suzuki N; Miyagoe-Suzuki Y; Imaizumi K; Takeda S J Gene Med; 2008 Jun; 10(6):702-13. PubMed ID: 18338831 [TBL] [Abstract][Full Text] [Related]
11. The utrophin promoter A drives high expression of the transgenic LacZ gene in liver, testis, colon, submandibular gland, and small intestine. Takahashi J; Itoh Y; Fujimori K; Imamura M; Wakayama Y; Miyagoe-Suzuki Y; Takeda S J Gene Med; 2005 Feb; 7(2):237-48. PubMed ID: 15538725 [TBL] [Abstract][Full Text] [Related]
12. Poloxamer 188 failed to prevent exercise-induced membrane breakdown in mdx skeletal muscle fibers. Quinlan JG; Wong BL; Niemeier RT; McCullough AS; Levin L; Emanuele M Neuromuscul Disord; 2006 Dec; 16(12):855-64. PubMed ID: 17118658 [TBL] [Abstract][Full Text] [Related]
13. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice. Schertzer JD; Ryall JG; Lynch GS Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899 [TBL] [Abstract][Full Text] [Related]
14. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype. Yoshimura M; Sakamoto M; Ikemoto M; Mochizuki Y; Yuasa K; Miyagoe-Suzuki Y; Takeda S Mol Ther; 2004 Nov; 10(5):821-8. PubMed ID: 15509500 [TBL] [Abstract][Full Text] [Related]
15. Utrophin A is essential in mediating the functional adaptations of mdx mouse muscle following chronic AMPK activation. Al-Rewashdy H; Ljubicic V; Lin W; Renaud JM; Jasmin BJ Hum Mol Genet; 2015 Mar; 24(5):1243-55. PubMed ID: 25324540 [TBL] [Abstract][Full Text] [Related]